KLWA
Kelly Lawrence W & Associates Portfolio holdings
AUM
$382M
This Quarter Return
+3.95%
1 Year Return
+13.86%
3 Year Return
+61.56%
5 Year Return
+124.1%
10 Year Return
+368.26%
AUM
$505M
AUM Growth
+$21.2M
(+4.4%)
Cap. Flow
+$5.86M
Cap. Flow
% of AUM
1.16%
Top 10 Holdings %
Top 10 Hldgs %
35.51%
Holding
232
New
2
Increased
25
Reduced
44
Closed
100
Top Buys
| 1 |
Under Armour
UAA
|
$6.47M |
| 2 |
AGN
Allergan plc
AGN
|
$6.41M |
| 3 |
Alkermes
ALKS
|
$1.37M |
| 4 |
Aptiv
APTV
|
$597K |
| 5 |
Broadridge
BR
|
$431K |
Top Sells
| 1 |
IBM
IBM
|
$3.04M |
| 2 |
Gilead Sciences
GILD
|
$2.7M |
| 3 |
Schlumberger
SLB
|
$674K |
| 4 |
Enovis
ENOV
|
$500K |
| 5 |
3M
MMM
|
$483K |
Sector Composition
| 1 | Healthcare | 19.81% |
| 2 | Financials | 19.4% |
| 3 | Technology | 18.33% |
| 4 | Consumer Staples | 11.07% |
| 5 | Consumer Discretionary | 10.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Mondelez International
MDLZ
$79.3B
| $8.37M | 1.66% |
193,880
+2,275
| +1% | +$98.3K |
|
27
Aflac
AFL
$57.1B
| $7.81M | 1.54% |
200,970
| – | – |
|
28
Goldman Sachs
GS
$221B
| $7.52M | 1.49% |
33,867
+560
| +2% | +$124K |
|
29
Chevron
CVX
$318B
| $7.3M | 1.44% |
69,966
-2,240
| -3% | -$234K |
|
|
30
Enovis
ENOV
$1.75B
| $7.03M | 1.39% |
103,709
-7,378
| -7% | -$500K |
|
|
31
Alkermes
ALKS
$4.95B
| $6.85M | 1.35% |
118,100
+23,700
| +25% | +$1.37M |
|
|
32
Under Armour
UAA
$2.17B
| $6.47M | 1.28% |
+297,180
| New | +$6.47M |
|
33
Eaton
ETN
$134B
| $6.34M | 1.25% |
81,480
+3,050
| +4% | +$237K |
|
|
34
Schlumberger
SLB
$52.2B
| $6.16M | 1.22% |
93,611
-10,235
| -10% | -$674K |
|
35
Alphabet (Google) Class C
GOOG
$2.79T
| $6M | 1.19% |
131,940
| – | – |
|
36
Edwards Lifesciences
EW
$47.7B
| $5.58M | 1.1% |
141,600
+1,800
| +1% | +$70.9K |
|
37
JPMorgan Chase
JPM
$824B
| $5.54M | 1.1% |
60,557
| – | – |
|
38
Cisco
CSCO
$268B
| $5.05M | 1% |
161,271
+5,900
| +4% | +$185K |
|
39
Applied Materials
AMAT
$124B
| $4.93M | 0.98% |
119,320
-11,000
| -8% | -$454K |
|
40
Procter & Gamble
PG
$370B
| $3.43M | 0.68% |
39,305
-2,378
| -6% | -$207K |
|
41
Vertex Pharmaceuticals
VRTX
$102B
| $2.72M | 0.54% |
21,087
| – | – |
|
|
42
3M
MMM
$81B
| $2.25M | 0.45% |
12,943
-2,775
| -18% | -$483K |
|
|
43
Gilead Sciences
GILD
$140B
| $2.1M | 0.41% |
29,605
-38,150
| -56% | -$2.7M |
|
44
GE Aerospace
GE
$293B
| $2.06M | 0.41% |
15,921
-208
| -1% | -$26.9K |
|
45
AbbVie
ABBV
$374B
| $1.94M | 0.38% |
26,695
| – | – |
|
46
Exxon Mobil
XOM
$477B
| $1.53M | 0.3% |
18,918
-200
| -1% | -$16.1K |
|
47
Albemarle
ALB
$9.43B
| $1.47M | 0.29% |
13,958
-400
| -3% | -$42.2K |
|
|
RDS.A
48
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
| $1.47M | 0.29% |
27,574
| – | – |
|
|
CYS.PRB
49
DELISTED
CYS Investments, Inc.
CYS.PRB
| $1.43M | 0.28% |
58,650
+6,300
| +12% | +$154K |
|
50
WELLS FARGO 7.5% NON CUMV PERP CONV
WFC.PRL
$4.84B
| $1.37M | 0.27% |
1,045
| – | – |
|